Certificate Under Regulation 74(5) of SEBI ( Depository and Participants) Regulation, 2018 for the 2nd Quarter Ended 30th September, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Welcure Drugs & Pharmaceuticals has submitted a routine compliance certificate to BSE for the quarter ended 30 September 2025, as required under Regulation 74(5) of SEBI's Depository and Participants Regulations, 2018. The certificate, issued by the company's Registrar and Transfer Agent (Skyline Financial Services), confirms that physical share certificates received for demat conversion during the quarter were verified, mutilated, cancelled, and the depository was recorded as the registered owner within the required 15-day timeframe. No share certificate details, share counts, or financial figures are disclosed in this filing.
This is a standard quarterly procedural compliance filing with no material effect on the company's financials, operations, or stock price. Investors need not take any action.